Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.35+0.01 (+2.91%)
Close on Nov 18, 2026Market cap $3.05MP/E 0.3Yield –
Evogene free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$13.64M. The highest annual figure on record is -$12.50M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.64M | – |
| FY2024 | Dec 31, 2024 | -$20.33M | – |
| FY2023 | Dec 31, 2023 | -$22.15M | – |
| FY2022 | Dec 31, 2022 | -$24.85M | – |
| FY2021 | Dec 31, 2021 | -$25.56M | – |
| FY2020 | Dec 31, 2020 | -$20.20M | – |
| FY2019 | Dec 31, 2019 | -$18.57M | – |
| FY2018 | Dec 31, 2018 | -$15.54M | – |
| FY2017 | Dec 31, 2017 | -$16.52M | – |
| FY2016 | Dec 31, 2016 | -$12.50M | – |
| FY2015 | Dec 31, 2015 | -$14.41M | – |
See a number that looks wrong?